Bruker Announces Acquisition of Canopy Biosciences, LLC
Strengthens Bruker in Targeted Multi-Omics and High-Plex Biomarker Imaging
16-Sep-2020 -
Bruker Corporation announced the acquisition of Canopy Biosciences, LLC, a leader in high multiplex biomarker imaging for immunology, immuno-oncology and cell therapy. This acquisition enhances Bruker’s offering in targeted multi-omics and fluorescence-based imaging techniques. Bruker’s global ...
acquisitions
biomarker
Bruker
+1